Reynders McVeigh Capital Management, LLC - Q2 2019 holdings

$932 Million is the total value of Reynders McVeigh Capital Management, LLC's 214 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was - .

 Value Shares↓ Weighting
ALC NewAlcon Inc$3,669,00059,134
+100.0%
0.39%
RDFN NewRedfin Corp$1,228,00068,315
+100.0%
0.13%
DD NewDuPont de Nemours Inc$646,0008,604
+100.0%
0.07%
DOW NewDow Inc$389,0007,879
+100.0%
0.04%
SSTI NewShotSpotter Inc$392,0008,880
+100.0%
0.04%
DISCK NewDiscovery Communications Ser C$326,00011,475
+100.0%
0.04%
ARRY NewArray BioPharma Inc$273,0005,900
+100.0%
0.03%
CTVA NewCorteva Inc$261,0008,835
+100.0%
0.03%
HAS NewHasbro Inc$258,0002,440
+100.0%
0.03%
MET NewMetLife Inc$244,0004,922
+100.0%
0.03%
TXN NewTexas Instruments Inc$216,0001,880
+100.0%
0.02%
QQQ NewPowershares Qqq Trust Unit Serunit ser 1$204,0001,091
+100.0%
0.02%
POR NewPortland Gen Elec Co$200,0003,700
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MasterCard Inc Cl A42Q3 20234.8%
ROCKWELL AUTOMATION INC42Q3 20234.2%
PROCTER & GAMBLE CO42Q3 20235.9%
CVS Health Corporation42Q3 20235.7%
CANADIAN NATL RY CO42Q3 20233.5%
JOHNSON & JOHNSON42Q3 20234.0%
DANAHER CORP DEL42Q3 20234.6%
Novartis AG Sp ADR42Q3 20234.0%
ILLUMINA INC42Q3 20233.3%
Walt Disney Co42Q3 20233.6%

View Reynders McVeigh Capital Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-07
13F-HR2024-02-07
13F-HR2023-11-09
13F-HR2023-08-09
13F-HR2023-05-03
13F-HR2023-02-10
13F-HR2022-11-08
13F-HR2022-08-05
13F-HR2022-05-11
13F-HR2022-02-11

View Reynders McVeigh Capital Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported number of holdings is incorrect (214 != 213)

Export Reynders McVeigh Capital Management, LLC's holdings